Organon & Co. OGN
Organon & Co. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($6.84); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Organon & Co. trades at about 19× earnings — above its 10-year norm (10-year range 4.2×–11.9×, median 6×).
Shaded band = 10-year range (4.2×–11.9×); dot = today's 19×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Gross margin | 53.3% | 58.0% | 59.8% | 62.8% | — | — |
| Net margin | 3.0% | 13.5% | 16.3% | 14.9% | 21.4% | 33.1% |
| FCF margin | 8.7% | 11.9% | 8.7% | 10.7% | 31.2% | 31.1% |
| Return on assets | 1.5% | 6.6% | 8.5% | 8.4% | 12.6% | 21.4% |
| Return on equity | 24.9% | 183.1% | -1461.4% | -102.8% | -89.6% | 39.4% |
| Debt / equity | 11.49× | 18.81× | -125.14× | -9.99× | -6.06× | 0.00× |
| Current ratio | 1.82 | 1.60 | 1.54 | 1.56 | 1.45 | 1.33 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.